The BICRHOME study was a prospective, multicenter study enrolling 312 cirrhotic patients with BSI. In this secondary analysis we selected patients receiving TZP or carbapenems as adequate empiric treatment. The 30-day mortality of patients receiving C/EI or intermittent infusion of TZP or carbapenems was assessed with Kaplan-Meier curves, Cox-regression model and estimation of the average treatment effect (ATE) using propensity score matching.
Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study
Bartoletti, Michele;Giannella, Maddalena;Lewis, Russell E;Caraceni, Paolo;Tedeschi, Sara;Baldassarre, Maurizio;Verucchi, Gabriella;Domenicali, Marco;Bernardi, Mauro;Viale, Pierluigi
2019
Abstract
The BICRHOME study was a prospective, multicenter study enrolling 312 cirrhotic patients with BSI. In this secondary analysis we selected patients receiving TZP or carbapenems as adequate empiric treatment. The 30-day mortality of patients receiving C/EI or intermittent infusion of TZP or carbapenems was assessed with Kaplan-Meier curves, Cox-regression model and estimation of the average treatment effect (ATE) using propensity score matching.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Bartoletti_2019.pdf
accesso aperto
Tipo:
Preprint
Licenza:
Licenza per Accesso Aperto. Altra tipologia di licenza compatibile con Open Access
Dimensione
1.24 MB
Formato
Adobe PDF
|
1.24 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
